{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:31:31Z","timestamp":1789903891909,"version":"4.0.1"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2014,9,3]],"date-time":"2014-09-03T00:00:00Z","timestamp":1409702400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0106130","type":"journal-article","created":{"date-parts":[[2014,9,3]],"date-time":"2014-09-03T17:55:19Z","timestamp":1409766919000},"page":"e106130","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["Association of Serum Uric Acid and Coronary Artery Disease in Premenopausal Women"],"prefix":"10.1371","volume":"9","author":[{"given":"Jian-wei","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-jie","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-jun","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-wei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-jie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,9,3]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1300\/J013v35n01_06","article-title":"Prediction of coronary heart disease preventive behaviors in women: a test of the health belief model","volume":"35","author":"NS Ali","year":"2002","journal-title":"Women Health"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1067\/mhl.2002.126522","article-title":"Perception of risk for coronary heart disease in women undergoing coronary angiography","volume":"31","author":"KB King","year":"2002","journal-title":"Heart Lung"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4037\/ajcc2002.11.3.221","article-title":"Women\u2019s perception of personal cardiovascular risk and their risk-reducing behaviors","volume":"11","author":"S Oliver-Mcneil","year":"2002","journal-title":"Am J Crit Care"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1097\/00029330-200812010-00006","article-title":"Clinical and angiographic characteristics of premenopausal women with coronary artery disease","volume":"121","author":"KF Dou","year":"2008","journal-title":"Chin Med J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/acr.20065","article-title":"Hyperuricemia and coronary heart disease: a systematic review and meta-analysis","volume":"62","author":"SY Kim","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Ndrepepa G, Braun S, King L, Fusaro M, Tada T, <etal>et al<\/etal>. (2013). Uric acid and prognosis in angiography-proven coronary artery disease. European journal of clinical investigation, 43(3), 256\u2013266.","DOI":"10.1111\/eci.12039"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Ndrepepa G, Braun S, King L, Cassese S, Tada T, <etal>et al<\/etal>. (2013). Prognostic value of uric acid in patients with Type 2 diabetes mellitus and coronary artery disease. Clinical Science, 124(4), 259\u2013268.","DOI":"10.1042\/CS20120336"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Calvo RY, Araneta MR, Kritz-Silverstein D, Laughlin GA, Barrett-Connor E (2014). Relation of Serum Uric Acid to Severity of and Progression of Coronary Artery Calcium in Postmenopausal White and Filipino Women (from The Rancho Bernardo Study). The American Journal of Cardiology. 113(7), 1153\u20131158.","DOI":"10.1016\/j.amjcard.2013.12.022"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Ndrepepa G, Cassese S, Braun S, Fusaro M, King L, <etal>et al<\/etal>. (2013). A gender-specific analysis of association between hyperuricaemia and cardiovascular events in patients with coronary artery disease. Nutrition, Metabolism and Cardiovascular Diseases, 23(12), 1195\u20131201.","DOI":"10.1016\/j.numecd.2013.03.005"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Veeranna V, Zalawadiya S, Panaich S, Kottam A, Afonso L (2013). Uric acid and cardiovascular disease risk reclassification. Journal of the American College of Cardiology, 61(10_S).","DOI":"10.1016\/S0735-1097(13)61333-9"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Lin GM, Li YH, Zheng NC, Lai CP, Lin CL, <etal>et al<\/etal>. (2013). Serum uric acid as an independent predictor of mortality in high-risk patients with obstructive coronary artery disease: a prospective observational cohort study from the ET-CHD registry, 1997\u20132003. Journal of cardiology, 61(2), 122\u2013127.","DOI":"10.1016\/j.jjcc.2012.09.004"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Katsiki N, Karagiannis A, Athyros VG, Mikhailidis DP (2013). Hyperuricaemia: more than just a cause of gout?. Journal of Cardiovascular Medicine, 14(6), 397\u2013402.","DOI":"10.2459\/JCM.0b013e3283595adc"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"Med359","author":"DI Feig","year":"2008","journal-title":"N Engl J"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.atherosclerosis.2005.06.041","article-title":"Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of coronary heart disease among US women","volume":"186","author":"JK Pai","year":"2006","journal-title":"Atherosclerosis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1056\/NEJM199802123380706","article-title":"Chemokines-chemotactic cytokines that mediate inflammation","volume":"338","author":"AD Luster","year":"1998","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s12265-011-9296-9","article-title":"Alterations in platelet function and cell-derived microvesicles in recently menopausal women: relationship to metabolic syndrome and atherogenic risk","volume":"4","author":"M Jayachandran","year":"2011","journal-title":"J Cardiovasc Transl Res"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/ncpendmet0245","article-title":"Mechanisms of disease: proatherogenic HDL\u2013an evolving field","volume":"2","author":"M Navab","year":"2006","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11883-006-0038-4","article-title":"High-density lipoprotein: is it always atheroprotective","volume":"Rep8","author":"BJ Ansell","year":"2006","journal-title":"Curr Atheroscler"},{"key":"ref19","first-page":"3345","article-title":"High plasma high-density lipoprotein levels, very low cardiovascular risk profile, and subclinical carotid atherosclerosis in postmenopausal women","author":"S Keidar","year":"2009","journal-title":"J of Clin Lipidol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1161\/ATVBAHA.110.207977","article-title":"Cholesteryl Ester Transfer Protein Polymorphism (TaqIB) Associates With Risk in Postinfarction Patients With High CReactive Protein and High-Density Lipoprotein Cholesterol Levels","volume":"30","author":"JP Corsetti","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1097\/MOL.0b013e3282364a17","article-title":"The paradox of dysfunctional high-density lipoprotein","volume":"18","author":"BJ Ansell","year":"2007","journal-title":"Curr Opin Lipidol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1161\/ATVBAHA.110.209544","article-title":"Increased Coronary Heart Disease Risk Determined by High High-Density Lipoprotein Cholesterol and C-Reactive Protein: Modulation by Variation in the CETP Gene","volume":"30","author":"RP Dullaart","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"e126","DOI":"10.1016\/j.atherosclerosis.2007.01.021","article-title":"Inflammation, atherosclerotic burden and cardiovascular prognosis","volume":"195(2)","author":"C Espinola-Klein","year":"2007","journal-title":"Atherosclerosis"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.amjcard.2007.01.049","article-title":"Impact of metabolic syndrome on atherosclerotic burden and cardiovascular prognosis","volume":"99","author":"C Espinola-Klein","year":"2007","journal-title":"Am J Cardiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMra0800885","article-title":"Uric acid and cardiovascular risk","volume":"359","author":"DI Feig","year":"2008","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.3949\/ccjm.73.12.1059","article-title":"Role of uric acid in hypertension, renal disease, and metabolic syndrome","volume":"73","author":"M Heinig","year":"2006","journal-title":"Cleve Clin J Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2741\/3950","article-title":"Uric acid, hyperuricemia and vascular diseases","volume":"17","author":"M Jin","year":"2012","journal-title":"Front Biosci (Landmark Ed)"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/heartjnl-2012-302535","article-title":"The role of uric acid in the pathogenesis of human cardiovascular disease","volume":"99(11)","author":"M Kanbay","year":"2013","journal-title":"Heart"},{"key":"ref29","first-page":"118","article-title":"Effect of statin treatment on renal function and serum uric acid levels and their relation to vascular events in patients with coronary heart disease and metabolic syndrome A subgroup analysis of the GREek Atorvastatin and Coronary heart disease Evaluation (GREACE) Study","volume":"22(1)","author":"VG Athyros","year":"2007","journal-title":"Nephrol Dial Transplant"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0106130","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,2]],"date-time":"2024-06-02T06:24:31Z","timestamp":1717309471000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0106130"}},"subtitle":[],"editor":[{"given":"Fengfeng","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,9,3]]},"references-count":29,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2014,9,3]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0106130","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,3]]}}}